Search Results 321-330 of 16996 for pharmacogenetics
Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
The specific aim of this protocol is to identify microRNAs that are differentially expressed between diseased fibrotic tissue (dupuytrens disease and plantar ...
Ixazomib citrate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as lenalidomide ...
The purpose of this study is to develop and validate full gene-sequencing assays or known mutation sequencing assays for the evaluation of patients with ...
The purpose of this study is to compare the effects on low-risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no ...
As scientists at the Mayo Clinic Center for Individualized Medicine discover new ways to use genomic information in the diagnosis, treatment and prevention of ...
In the Breast Cancer Genome-Guided Therapy (BEAUTY) study, she has identified biomarkers for selection and repurposed a class of epigenetic drugs to treat ...
Project 2 in the Mayo Clinic Multiple Myeloma SPORE focuses on insights into biological pathways influencing responsiveness to therapy and subsequent ...
The purpose of this study is to evaluate response, survival, safety, and tolerability of treatment with lenvatinib for patients who have anaplastic thyroid ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.